Description of Collaborative Activity: |
The Biomarkers Consortium develops, validates, and qualifies biological markers (biomarkers) to speed the development of medicines and therapies for detection, prevention, diagnosis, and treatment of disease and improve patient care. The NIH Public Private Partnership Program coordinates NIH participation in the sponsored Biomarkers Foundation for the National Institutes of Health (FNIH) consortium. The consortium is an umbrella which encompasses research projects, ongoing working groups, as well as occasional workshops and conferences. |
NIH Participating Institutes/Centers/Office of the Director: |
NCI, NHLBI, NIA, NIAID, NIAMS, NIBIB, NICHD, NIDDK, NIMH, NINDS |
